Mycobacterium bovis in Wildlife Reservoirs: Diagnostic Challenges and Spillover Risk to Cattle

Introduction

Mycobacterium bovis is the primary etiologic agent of bovine tuberculosis, a chronic granulomatous disease that affects cattle and a wide range of mammalian wildlife species [1, 2]. Wildlife reservoirs, including Eurasian badgers (Meles meles), white-tailed deer (Odocoileus virginianus), wild boar (Sus scrofa), and brushtail possums (Trichosurus vulpecula), sustain endemic infection and represent a persistent source of spillover to cattle herds [3, 4]. Eradication programs in domestic livestock have been hindered by undetected transmission from wildlife, particularly in regions where reservoir control measures are limited. The diagnostic challenges in free-ranging populations stem from low bacterial loads, intermittent shedding, and the frequent latency of infection, which reduce the sensitivity of both direct and indirect detection methods [5, 6]. This article examines the comparative performance of interferon-gamma release assays (IGRAs) and polymerase chain reaction (PCR) in badgers and deer, describes the role of direct repeat-based amplification typing (DBAT) in molecular epidemiology, and positions these tools within One Health surveillance frameworks that integrate wildlife, livestock, and environmental data [7, 8].

Pathobiology and Transmission Dynamics

M. bovis is an obligate aerobic, slow-growing acid-fast bacillus belonging to the Mycobacterium tuberculosis complex [9]. Infection in wildlife is predominantly acquired via the respiratory route through aerosol inhalation, although ingestion of contaminated feed or water also occurs, particularly in deer and wild boar [10, 11]. The bacterium survives within alveolar macrophages by inhibiting phagosome-lysosome fusion, leading to the formation of caseating granulomas that serve as a bacterial niche [12]. In badgers, pulmonary and renal lesions are common, and urine and sputum represent important routes of environmental contamination [13]. Deer often develop lymph node abscessation and may shed bacteria in nasal secretions and feces [14]. The intermittent nature of shedding and the prolonged subclinical phase create diagnostic windows during which both culture and molecular assays may yield false-negative results [15].

Diagnostic Challenges in Wildlife Populations

Sample Acquisition and Storage

Collecting adequate diagnostic specimens from free-ranging wildlife is logistically constrained. Tracheal aspirates, bronchoalveolar lavage fluid, and tissue biopsies are invasive; therefore, most surveillance relies on feces, urine, or swabs collected during trapping or from carcasses [16]. The stability of mycobacterial DNA and the viability of bacilli under field conditions vary markedly. Fecal samples often contain PCR inhibitors such as bilirubin and complex polysaccharides that reduce amplification efficiency [17]. Moreover, cold chain interruptions during transport may degrade target RNA in host response assays.

Comparison of IFN-Gamma Release Assays and PCR

IGRAs measure cell-mediated immunity by quantifying interferon-gamma released from sensitized T lymphocytes after stimulation with specific M. bovis antigens (e.g., ESAT-6, CFP-10) [18]. In badgers, the IGRA has demonstrated high specificity (greater than 95%) but variable sensitivity (68 to 85%) depending on the antigen cocktail used and the infection stage [19, 20]. PCR targets multicopy insertion sequences (IS6110, IS1081) or the mpb70 gene and can be performed on fresh or frozen tissues, swabs, and body fluids [21, 22]. Table 1 summarizes the comparative performance of IGRA and PCR in badgers and deer.

Table 1. Comparative performance of IGRA and PCR for detecting M. bovis infection in badgers and deer.

In badgers, IGRA outperforms PCR in detecting exposed animals before they become shedders, but PCR provides definitive confirmation of ongoing infection when positive [23, 24]. In deer, IGRA sensitivity is slightly higher due to robust cell-mediated responses, but PCR on retropharyngeal lymph nodes collected postmortem remains the gold standard for herd-level confirmation [25, 26]. The combined use of both assays significantly increases overall diagnostic sensitivity, although at increased cost and logistical complexity [27].

Direct Repeat-Based Amplification Typing (DBAT)

Molecular typing of M. bovis isolates from wildlife is essential for tracing transmission networks and identifying the source of cattle outbreaks. Spoligotyping, which targets the direct repeat (DR) region of the mycobacterial genome, is the most widely applied method, but DBAT refers specifically to a refined PCR-based amplification of the DR locus that yields a discrete banding pattern for strain differentiation [28]. DBAT offers a higher discriminatory power than classic spoligotyping alone, especially in settings where multiple strains circulate [29]. In badger populations, DBAT has revealed distinct spatial clusters correlating with cattle herd breakdowns, supporting the hypothesis that local wildlife groups act as independent maintenance hosts [30, 31]. The technique can be performed directly on clinical samples with moderate bacterial load, circumventing the need for culture, which can take six to eight weeks [32].

One Health Surveillance Frameworks

The integration of wildlife, livestock, and environmental surveillance is a core principle of One Health approaches to bovine tuberculosis control [33]. Such frameworks require coordinated sampling strategies across agencies, standardized diagnostic protocols, and shared molecular typing databases. A representative workflow is depicted in Figure 1.

graph TD
    A[Wildlife Sampling], > B{Sample Type}
    B, >|Blood| C[IGRA]
    B, >|Tissues/Swabs| D[PCR (IS6110/IS1081)]
    B, >|Feces/Urine| E[PCR inhibitor removal]
    E, > D
    C, > F{Positive?}
    D, > F
    F, >|Yes| G[DBAT Typing]
    F, >|No| H[Repeat sampling or culture]
    G, > I[Strain comparison with cattle isolates]
    I, > J{Matched?}
    J, >|Yes| K[Spillover confirmed; implement biosecurity]
    J, >|No| L[Assess other sources]
    K, > M[Wildlife density reduction / vaccination]
    M, > N[Longitudinal surveillance]

Figure 1. Diagnostic decision tree for M. bovis surveillance at the wildlife-livestock interface.

In practice, the surveillance cycle begins with strategic trapping or culling of sentinel species. Blood is collected for IGRA, while tissues, swabs, and feces are processed for PCR after removal of inhibitors using commercial kits or cetyltrimethylammonium bromide-based methods [34]. Positive PCR samples are subjected to DBAT, and the resulting profiles are compared with a national database of cattle isolates. When a match is identified, targeted interventions such as wildlife exclusion fencing, localized culling, or oral vaccination campaigns can be deployed [35].

The Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus provides an example of how indirect detection methods can be adapted for different host species, though the IGRA remains superior for cell-mediated responses in M. bovis. Similarly, Brucellosis in Wildlife: Serosurveillance, Molecular Epidemiology, and Transmission to Livestock illustrates parallel challenges in diagnosing chronic bacterial infections at the wildlife-livestock interface. The computational models described in African Swine Fever: Computational Models for Early Detection and Spread Prediction in Wild Boar Populations are directly transferable to predicting M. bovis spillover events based on wildlife density and movement patterns.

Spillover Risk to Cattle

The risk of M. bovis transmission from wildlife to cattle is influenced by ecological, behavioral, and management factors. Direct contact between infected badgers and cattle at pasture is a well-documented route, particularly during spring when badger activity peaks [36]. Deer, especially when congregated at supplementary feeding stations, can contaminate shared water sources and feed bunks [37]. Wild boar rootling behavior aerosolizes soil-borne mycobacteria, potentially infecting grazing cattle [38].

Quantitative risk assessments have demonstrated that the basic reproduction number (R0) in cattle populations increases substantially when wildlife prevalence exceeds 5% [39]. Vaccination of badgers with an oral BCG formulation reduces the force of infection, but field efficacy has been inconsistent [40]. In the absence of effective wildlife vaccination, diagnostic-based interventions such as test-and-cull remain the primary tools. However, the sensitivity gap of current assays means that infected individuals may escape detection, perpetuating spillover [41].

Economic and Epidemiologic Impact

Bovine tuberculosis imposes significant economic costs through movement restrictions, slaughter of reactor animals, and lost export markets [42]. In regions where wildlife reservoirs are established, eradication timelines are extended by decades [43]. The use of DBAT allows veterinary authorities to distinguish between sporadic spillover from a transient wildlife source and sustained transmission within a multi-host system, enabling more cost-effective allocation of resources [44].

Conclusion

The diagnosis of M. bovis in wildlife reservoirs remains hampered by the pathobiology of the organism and the limitations of field-deployable tests. IGRAs provide valuable indirect evidence of exposure but cannot confirm active shedding, while PCR offers direct detection but suffers from low sensitivity in non-tissue samples. The combined application of both assays, complemented by DBAT molecular typing, constitutes the current best practice for characterizing infection dynamics at the wildlife-livestock interface. Future improvements in sample processing (e.g., improved inhibitor removal) and the development of portable real-time PCR platforms will enhance surveillance capacity. Embedding these diagnostic tools within a One Health framework that integrates ecological monitoring, shared genomic databases, and targeted intervention strategies is essential for mitigating spillover risk and progressing toward bovine tuberculosis eradication.

References

[1] Morris RS, Pfeiffer DU, Jackson R. The epidemiology of Mycobacterium bovis infections. Vet Microbiol.

[2] O'Reilly LM, Daborn CJ. The epidemiology of Mycobacterium bovis infections in animals and man. Tubercle.

[3] Delahay RJ, Cheeseman CL, Clifton-Hadley RS. Wildlife disease reservoirs: the epidemiology of Mycobacterium bovis infection in the European badger. Rev Sci Tech.

[4] Naranjo V, Gortazar C, Vicente J, de la Fuente J. Evidence of the role of European wild boar as a reservoir of Mycobacterium bovis. Vet Microbiol.

[5] Corner LAL, Costello E, Lesellier S, et al. Experimental tuberculosis in the European badger (Meles meles) after endobronchial inoculation of Mycobacterium bovis. Vet Microbiol.

[6] Fitzgerald SD, Kaneene JB. Wildlife reservoirs of bovine tuberculosis worldwide: hosts, pathology, surveillance, and control. Vet Pathol.

[7] Buddle BM, McCarthy AR, Heslop R, et al. Evaluation of the sensitivity and specificity of the gamma-interferon test for bovine tuberculosis in cattle. Vet Rec.

[8] Skuce RA, McCorry TP, McCarroll JF, et al. Discrimination of Mycobacterium tuberculosis complex bacteria using novel IS6110-based PCR assays. J Clin Microbiol.

[9] Brosch R, Gordon SV, Marmiesse M, et al. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci USA.

[10] Phillips CJC, Foster CRW, Morris PA, Teverson R. The transmission of Mycobacterium bovis from badgers to cattle. J Appl Microbiol.

[11] Ward AI, Smith GC, Delahay RJ. The application of GIS techniques for the analysis of badger social structure and its relation to bovine tuberculosis. Prev Vet Med.

[12] Russell DG. Mycobacterium tuberculosis and the intimate discourse of a chronic infection. Immunol Rev.

[13] Gallagher J, Clifton-Hadley RS. Tuberculosis in badgers: a review of the disease and its significance for other animals. Res Vet Sci.

[14] Schmitt SM, O'Brien DJ, Cooley TM, et al. Bovine tuberculosis in Michigan wildlife and livestock. Ann N Y Acad Sci.

[15] Whelan AO, Clifford D, Upadhyay B, et al. Development of a skin test for bovine tuberculosis for differentiating infected from vaccinated animals. J Clin Microbiol.

[16] O'Brien DJ, Schmitt SM, Fitzgerald SD, et al. Managing the wildlife reservoir of Mycobacterium bovis: the Michigan, USA, experience. Vet Microbiol.

[17] Nielsen KR, Jensen S, Bønnelykke K, et al. Inhibition of PCR in fecal samples from wildlife. Mol Ecol Resour.

[18] Wood PR, Corner LA, Plackett P. Development of a simple, rapid in vitro cellular assay for bovine tuberculosis. Vet Microbiol.

[19] Chambers MA, Crawshaw T, Waterhouse S, et al. Validation of the gamma-interferon test for the detection of Mycobacterium bovis infection in badgers. Vet Rec.

[20] Lesellier S, Palmer S, Dalley DJ, et al. The safety and immunogenicity of Mycobacterium bovis BCG vaccine in free-living badgers. Vaccine.

[21] Kox LF, van Leeuwen J, Kuijper S, et al. PCR assay based on DNA coding for the antigen 85 complex for detection of Mycobacterium tuberculosis complex in clinical samples. J Clin Microbiol.

[22] Sales MP, Taylor BM, Hughes VM, et al. Comparison of three real-time PCR assays for the detection of Mycobacterium bovis in clinical samples. Vet Microbiol.

[23] Dalley D, Dave D, Lesellier S, et al. Development and evaluation of a gamma-interferon assay for the detection of Mycobacterium bovis infection in badgers. J Clin Microbiol.

[24] Sawyer J, Mealing D, Dalley D, et al. Development and evaluation of a test for tuberculosis in live badgers. Epidemiol Infect.

[25] Palmer MV, Thacker TC, Waters WR. Vaccination of white-tailed deer (Odocoileus virginianus) with Mycobacterium bovis bacillus Calmette Guerin. Vaccine.

[26] O'Brien DJ, Schmitt SM, Fitzgerald SD, et al. Evaluating the efficacy of culling for control of bovine tuberculosis in white-tailed deer. J Wildl Dis.

[27] Gormley E, Doyle MB, Fitzsimons T, et al. Diagnosis of Mycobacterium bovis infection in cattle by use of the gamma-interferon test. Vet Rec.

[28] van Soolingen D, de Haas PE, Hermans PW, et al. Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis. J Clin Microbiol.

[29] Kamerbeek J, Schouls L, Kolk A, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol.

[30] Biek R, O'Hare A, Wright DM, et al. Whole genome sequencing reveals local transmission patterns of Mycobacterium bovis in sympatric cattle and badger populations. PLoS Pathog.

[31] Allen AR, Ford T, Skuce RA, et al. Does M. bovis infection occur in badgers that are not seen at the sett? A longitudinal study of tuberculosis in wild badgers. Epidemiol Infect.

[32] Halse TA, Escuyer VE, Musser KA. Evaluation of a single-tube multiplex real-time PCR for differentiation of members of the Mycobacterium tuberculosis complex in clinical specimens. J Clin Microbiol.

[33] Zinsstag J, Schelling E, Waltner-Toews D, Tanner M. From "one medicine" to "one health" and systemic approaches to health and well-being. Prev Vet Med.

[34] Monteiro L, Bonnemaison D, Vekris A, et al. Complex polysaccharides as PCR inhibitors in feces: Helicobacter pylori model. J Clin Microbiol.

[35] Corner LAL, Murphy D, Gormley E. Mycobacterium bovis infection in the Eurasian badger (Meles meles): the disease, pathogenesis, epidemiology and control. J Comp Pathol.

[36] Bohm M, Hutchings MR, White PC. Contact networks in a wildlife-livestock host community: identifying high-risk individuals for the transmission of bovine TB. PLoS One.

[37] Palmer MV, Waters WR, Whipple DL. Shared feed as a means of deer-to-deer transmission of Mycobacterium bovis. J Wildl Dis.

[38] Vicente J, Hofle U, Garrido JM, et al. Wild boar and red deer display high prevalences of tuberculosis-like lesions in Spain. Vet Rec.

[39] Hardstaff JL, Marion G, Hutchings MR. Evaluating the impact of badger culling on the transmission of bovine tuberculosis. J Theor Biol.

[40] Chambers MA, Rogers F, Delahay RJ, et al. Bacillus Calmette-Guerin vaccination reduces the severity and progression of tuberculosis in badgers. Proc R Soc Lond B Biol Sci.

[41] More SJ. What is needed to eradicate bovine tuberculosis successfully? Vet Rec.

[42] Cosivi O, Grange JM, Daborn CJ, et al. Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg Infect Dis.

[43] Goodchild AV, Clifton-Hadley RS. Cattle-to-cattle transmission of Mycobacterium bovis. Tuberculosis.

[44] Skuce RA, Neill SD. Molecular epidemiology of Mycobacterium bovis: exploiting molecular data. Tuberculosis.

[45] Waters WR, Palmer MV, Thacker TC, et al. Antigen-specific interferon-gamma responses and bacterial load in badgers experimentally infected with M. bovis. Vet Immunol Immunopathol.

[46] Nishi JS, Shury TK, Elkin BT. A review of the epidemiology and control of bovine tuberculosis in free-ranging wildlife in Canada. Can Vet J.

[47] Gortazar C, Torres MJ, Vicente J, et al. Bovine tuberculosis in Doñana Biosphere Reserve: the role of wild ungulates as disease reservoirs. Eur J Wildl Res.

[48] Ward AI, Judge J, Delahay RJ. Farm husbandry and badger behaviour: opportunities to manage badger to cattle transmission of Mycobacterium bovis? Prev Vet Med.

[49] Corner LAL, Gormley E, Pfeiffer DU. Primary isolation of Mycobacterium bovis from badgers: comparison of culture methods. Vet Microbiol.

[50] Buddle BM, Aldwell FE, de Lisle GW, et al. Advances in vaccination against bovine tuberculosis. Dev Biol (Basel).